A Study to Evaluate Safety and Tolerability of QLS-101 in NTG

Completed · Phase 2

Conditions studied: Normal Tension Glaucoma (NTG)

In brief

A randomized active-controlled multi-site double-masked 28 day study to evaluate the safety and tolerability of QLS-101 versus timolol maleate Preservative Free (PF) 0.5% ophthalmic solution in subjects with normal tension glaucoma

Key facts

Study ID

NCT04857827

Run by

Qlaris Bio, Inc.

People needed

30

Starts

2021-09-15

Expected to finish

2022-08-26

Last updated by the study team

2025-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Visual acuity +1.0 logMAR or better
• Willing to give informed consent
• Ability to washout from current intraocular pressure lowering medications -

You may not qualify if…

• All secondary glaucomas
• Previous glaucoma intraocular or laser surgery (selective laser trabeculoplasty permitted when done 18 months or longer from Screening)
• Refractive surgery
• Ocular infection or inflammation

Where it is running

• Vance Thompson Vision — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.